Characterizing intact proviral HIV-1 reservoir size and determinants of reservoir dynamics in African populations

Information

  • Research Project
  • 10144932
  • ApplicationId
    10144932
  • Core Project Number
    U01AI152151
  • Full Project Number
    5U01AI152151-02
  • Serial Number
    152151
  • FOA Number
    RFA-AI-19-023
  • Sub Project Id
  • Project Start Date
    4/15/2020 - 5 years ago
  • Project End Date
    3/31/2025 - 7 months ago
  • Program Officer Name
    NOVAK, LEIA KAYE
  • Budget Start Date
    4/1/2021 - 4 years ago
  • Budget End Date
    3/31/2022 - 3 years ago
  • Fiscal Year
    2021
  • Support Year
    02
  • Suffix
  • Award Notice Date
    4/8/2021 - 4 years ago
Organizations

Characterizing intact proviral HIV-1 reservoir size and determinants of reservoir dynamics in African populations

Project Summary Antiretroviral treatment is unable to clear HIV-1 infection because a highly stable latent viral reservoir persists in the host. Key areas of interest with respect to HIV-1 eradication strategies include latent reservoir establishment, size and make-up. A considerable amount is now known about these key areas in subtype B-infected American men, yet there remains limited knowledge in the most affected population, subtype C-infected South African women, or in African populations in general. Population differences may exist with respect to reservoir characteristics, and eradication strategies would need to take such differences into account. Characterization of the HIV-1 reservoir in the African context therefore represents a much needed area of attention. This project proposes to firstly address the need for implementation of a high-throughput, accurate reservoir sizing method in South Africa through optimization of the newly developed intact proviral DNA assay (IPDA) for subtype C HIV-1. This method will be applied to more than 200 women from KwaZulu Natal. Reservoir size in these women will be compared to that of individuals from Ugandan and American cohorts using the same assay to evaulate reservoir differences across populations. This project will also investigate a role for the viral factors Nef and the long terminal repeat, which are drivers of immune evasion and gene transcription respectively, in reservoir size and make-up in a subset of these women. Finally, we will explore the contribution of viral variants from the blood and cervix to the long-lived reservoir in these women using Bayesian evolutionary analyses. We hypothesize that Nef-mediated MHC-I downregulation and LTR activity have independent effects on reservoir size and distribution, and these effects differ according to infecting subtype and study population. This project will allow for comparison of reservoir size across populations using a standardized assay and will evaluate determinants of size and kinetics of establishment.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    U01
  • Administering IC
    AI
  • Application Type
    5
  • Direct Cost Amount
    181790
  • Indirect Cost Amount
    10083
  • Total Cost
    191873
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    855
  • Ed Inst. Type
  • Funding ICs
    NIAID:191873\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    UNIVERSITY OF CAPE TOWN
  • Organization Department
  • Organization DUNS
    568227214
  • Organization City
    RONDEBOSCH
  • Organization State
  • Organization Country
    SOUTH AFRICA
  • Organization Zip Code
    7700
  • Organization District
    SOUTH AFRICA